Join us at the American Diabetes Association’s 84th Annual Scientific Sessions for a KOL discussion and Q&A session with Dr. David A. D’Alessio (Duke University School of Medicine) on Monday, June 24 from 7:00 AM – 8:00 AM ET. Our session will feature insights on the unmet medical need and evolving treatment landscape for patients living with #obesity and #T2D. Meet with several members from our management team who will discuss Fractyl’s novel platforms. RSVP to reserve your spot: https://lnkd.in/eig5dT8a A live webcast will be available on our website for those joining us virtually. #ADASciSessions #ADA2024
Fractyl Health’s Post
More Relevant Posts
-
Senior Communications Strategist - designer of smart, clear, and compelling communications
A little lesson on #pharmacogenomics and how it could soon be used to improve treatment of depression.
🎥 Check out our recent video about our exciting collaboration with The University of British Columbia and the UBC Department of Medicine on an innovative project focusing on pharmacogenomics and depression! Learn how PGx testing can improve patient outcomes and reduce healthcare costs. #PGx #Pharmacogenomics #DepressionCare
-
📢 Attend the ObesityWeek® 2023 conference, from October 14 to 17 in Dallas. If you haven't registered yet, it's not too late. Register today and join us. Don't miss out on this great experience to learn cutting-edge obesity research, latest clinical treatments, and network with leading experts! #OW2023 #ObesityScience #ObesityResearch
-
Today we are focusing on the TREAT component of our Learn- Treat - Cure initiative for our science and research strategy. To TREAT the disorder, the Dup15 Alliance will promote and support research that informs strategies to improve patient quality of life through symptom management and elimination. Let's break down how Dup 15q clinics play an important role in connecting patients to clinical trials, from our latest Science and Clinical Initiatives (SCI) Spotlight Newsletter. Read online here: https://lnkd.in/eSCAf_3u #Dup15qResearch #Believe #LearnTreatCure #Treat #Dup15qClinics
-
-
ProMedView is the go-to resource for complex Neuro COVID and Long COVID. Our program is built on evidence-based research and best practices. It features specialty clinical and medical services to provide objective assessments and targeted treatment to achieve the best possible outcomes and mitigate the risks associated with post viral syndrome. For a full list of services visit www.promedview.com. #neuroCOVID #LongCOVID #LongCOVIDresources #covid #longcovidawareness #covid19update #covid19
-
🩺 Dive into the latest issue of ePulmonology Review - Clinical Management Consideration in Mild Asthma. - with insights from Dr. Ashraf Fawzy of Johns Hopkins University School of Medicine. Learn about treatment strategies, risks, and benefits for providing optimal care to patients. Start your learning journey now! #AsthmaCare #ePulmonologyReview 📚👩⚕️ https://buff.ly/48I4jaq
-
-
Nurse Educator at The Institute for Johns Hopkins Nursing for the Johns Hopkins Hospital
🩺 Dive into the latest issue of ePulmonology Review - Clinical Management Consideration in Mild Asthma. - with insights from Dr. Ashraf Fawzy of Johns Hopkins University School of Medicine. Learn about treatment strategies, risks, and benefits for providing optimal care to patients. Start your learning journey now! #AsthmaCare #ePulmonologyReview 📚👩⚕️ https://buff.ly/48I4jaq
-
-
I'm pleased to announce the publication of my latest systematic review titled, "Effectiveness of Complementary and Alternative Medicine and Physical Therapies in Peripheral Arterial Disease with Intermittent Claudication". This comprehensive review evaluates the impact of various complementary and alternative medicine (CAM) practices, alongside physical therapies, on the management of peripheral arterial disease (PAD) with intermittent claudication. Our findings provide valuable insights and evidence-based recommendations that could enhance treatment approaches for this condition. I would like to express my heartfelt thanks to my co-authors and collaborators for their dedication and hard work. Your contributions were instrumental in making this review possible. 🔗 [https://lnkd.in/ddABAmBK] #Research #Publication #SystematicReview #PeripheralArterialDisease #IntermittentClaudication #ComplementaryMedicine #AlternativeMedicine #PhysicalTherapy #Healthcare #EvidenceBasedMedicine
-
-
What would you (or your child) do if you didn’t have to worry about lows? ⛄️ Learn more about HI clinical trials for a #FutureWithoutLows here: https://lnkd.in/eFM8cuE 💙🩵 #congentialhyperinsulinism #hyperinsulinism #hypoglycemia #raredisease
-
-
Want to learn why clinical inertia matters in #Obesity care and how you can enlist primary care to overcome it? Join Jaime Almandoz, MD, MBA, FTOS, and Angela Fitch MD, FACP, FOMA, Dipl. ABOM, on October 15th at 6:30 PM CDT during #OW2023 to do just that! https://lnkd.in/eh8JTN9U #MedEd This activity is supported by an educational grant from Eli Lilly and Company.
-
New publication in Diabetes Research and Clinical Practice provides a better understanding of the correlation between #MASLD and #T2D and a comprehensive review of the distinct role and effect of selective, dual and pan- PPARs, including lanifibranor. Read the full article here: https://lnkd.in/ei6zbMKz Michael Cooreman, Luisa Vonghia, Sven Francque #MASLD #PPAR #T2D $IVA
-
